Journals / Journal of Clinical Research in Pediatric Endocrinology / 2017 / Cilt: 9 - Sayı: 1

A Rare Cause of Short Stature: 3M Syndrome in a Patient with Novel Mutation in OBSL1 Gene

Pages
91–94
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is recommended that physicians pay further attention to this condition in the differential diagnosis of children with severe short stature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The Miller-McKusick-Malvaux (3M) syndrome is a rare autosomal disorder that can lead to short stature, dysmorphic features, and skeletal abnormalities with normal intelligence.
📊
Key Findings & Data:A 16-month-old female patient had been referred to our clinic due to short stature.
💡
Conclusion & Impact:It is recommended that physicians pay further attention to this condition in the differential diagnosis of children with severe short stature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The Miller-McKusick-Malvaux (3M) syndrome is a rare autosomal disorder that can lead to short stature, dysmorphic features, and skeletal abnormalities with normal intelligence. A 16-month-old female patient had been referred to our clinic due to short stature. Case history revealed a birth weight of 1740 grams on the 39th week of gestation, with a birth length of 42 cm and no prior hereditary conditions of clinical significance in her family. On physical examination, her length was 67 cm [-3.6 standard deviation (SD) score], weight 7.2 kg (-2.9 SD score), and head circumference 42 cm (below 3rd percentile). She also had numerous characteristic physical features such as a triangular face, fleshy nose tip, a long philtrum, prominent mouth and lips, pointed chin, lumbar lordosis, and prominent heels. As her growth retardation had a prenatal onset and the physical examination results were suggestive of a characteristic profile, the diagnosis of 3M syndrome was strongly considered. Genetic assessment of the patient revealed a novel homozygous p.T45Nfs*40 mutation in the OBSL1 gene. It is recommended that physicians pay further attention to this condition in the differential diagnosis of children with severe short stature.

🔖

Cite This Article

KESKİN, M., ŞAHİN, N. M., KURNAZ, E., BAYRAMOĞLU, E., ERDEVE, Ş. S., AYCAN, Z., ÇETİNKAYA, S. (2017). A Rare Cause of Short Stature: 3M Syndrome in a Patient with Novel Mutation in OBSL1 Gene. Journal of Clinical Research in Pediatric Endocrinology, Cilt: 9 - Sayı: 1, 91–94. https://ajindex.com/articles/270485

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Murray PG, Hanson D, Coulson T, Stevens A, Whatmore A, Poole RL, Mackay DJ, Black GC, Clayton PE. 3-M syndrome: a growth disorder associated with IGF2 silencing. Endocr Connect 2013;11;2:225-235
  2. Meazza C, Lausch E, Pagani S, Bozzola E, Calcaterra V, Superti-Furga A, Silengo M, Bozzola M. 3-M syndrome associated with growth hormone deficiency: 18 year follow-up of a patient. Ital J Pediatr 2013;39:21
  3. Huber C, Munnich A, Cormier-Daire V. The 3-M syndrome. Best Pract Res Clin Endocrinol Metab 2011;25:143-151
  4. Clayton PE, Hanson D, Magee L, Murray PG, Saunders E, Abu-Amero SN, Moore GE, Black GC. Exploring the spectrum of 3-M syndrome, a primordial short stature disorder of disrupted ubiquitination. Clin Endocrinol (Oxf) 2012;77:335-342
  5. Deeb A, Afandi O, Attia S, Fatih AE. 3-M syndrome: a novel CUL7 mutation associated with respiratory distress and a good response to GH therapy. Endocrinol Diabetes Metab Case Rep 2015;2015:150012. Epub 2015 Apr 1 6. Hanson D, Murray PG, Coulson T, Sud A, Omokanye A, Stratta E, Sakhinia F, Bonshek C, Wilson LC, Wakeling E, Temtamy SA, Aglan M, Rosser EM, Mansour S, Carcavilla A, Nampoothiri S, Khan WI, Banerjee I, Chandler KE, Black GC, Clayton PE. Mutations in CUL7, OBSL1 and CCDC8 in 3-M syndrome lead to disordered growth factor signalling. J Mol Endocrinol 2012;49:267-275
  6. Demir K, Altıncık A, Böber E. Severe short stature due to 3-M syndrome with a novel OBSL1 gene mutation. J Pediatr Endocrinol Metab 2013;26:147-150
  7. Holder-Espinasse M, Irving M, Cormier-Daire V. Clinical utility gene card for: 3-M syndrome - update 2013. Eur J Hum Genet 2014:22.Epub 2013 Jul 31 9. Hanson D, Murray PG, Black GC, Clayton PE. The genetics of 3-M syndrome: unravelling a potential new regulatory growth pathway. Horm Res Paediatr 2011;76:369-378. Epub 2011 Nov 29 10. van der Wala G, Ottenb BJ, Brunnera HG, van der Burgt I. 3-M syndrome: description of six new patients with review of the literature. Clin Dysmorphol 2001;10:241-252
  8. Güven A, Cebeci AN. 3-M syndrome: a report of four cases in two families. J Clin Res Pediatr Endocrinol 2011;3:154-159.